Do Patients With IBD Continue Using Pain Medication After Starting Advanced Therapy?
Researchers examined pain medication usage trends before and after initiating advanced therapy in patients newly diagnosed with inflammatory bowel disease.
Researchers examined pain medication usage trends before and after initiating advanced therapy in patients newly diagnosed with inflammatory bowel disease.
Researchers examined the association between obesity and risk for surgical procedures, hospitalization, and serious infections in patients with IBD treated with biologics.
Researchers examined the relationship between consuming ultra-processed foods and the incidence, prevalence, and outcomes of IBD.
Researchers examined the association between consuming processed food and risk for Crohn disease and ulcerative colitis.
Researchers sought to identify predictors of response or remission in ulcerative colitis after patients received tofacitinib maintenance therapy.
Researchers examined the association between race and ethnicity and pediatric Crohn disease diagnostic delay, treatment, and outcomes.
Researchers sought to identify predictive markers of ustekinumab response as well as evaluate the effect of its pharmacokinetics on the clinical and endoscopic outcomes among patients with Crohn disease.
Researchers sought to determine if ustekinumab and vedolizumab could help prevent postoperative recurrence in Crohn disease.
Although EEN remains the first-line induction treatment for children with Crohn disease, emerging research reveals favorable clinical outcomes for adults.
Researchers evaluated the effects of psychological health on prognosis for inflammatory bowel disease.